| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 122,411 | 134,306 | 147,090 | 171,580 | | Cost of Revenue | 101,544 | 110,742 | 125,245 | 172,734 | | | Gross Profit | 20,867 | 23,564 | 21,845 | (1,154) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,374 | 15,259 | 14,407 | 20,272 | | Non Recurring | 92 |
-
| 3,108 | 6,209 | | Others | 1,594 | 1,789 | 2,045 | 4,330 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,807 | 6,516 | 2,285 | (31,965) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 364 | 458 | (131) | (746) | | Earnings Before Interest And Taxes | 4,171 | 6,974 | 2,154 | (32,711) | | Interest Expense | 601 | 719 | 755 | 1,427 | | Income Before Tax | 3,570 | 6,255 | 1,399 | (34,138) | | Income Tax Expense | 1,290 | 2,094 | (1,772) | 13,586 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,280 | 4,161 | 3,171 | (47,724) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,280 | 4,161 | 3,171 | (47,724) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,280 | $4,161 | $3,171 | ($47,724) |
|
0.04% Nasdaq 
0.15%
Income Statement
